Importantly, in human brain UFM1 levels positively correlated with pathological tau levels (including insoluble total tau, soluble phosphorylated tau (p-tau), and insoluble p-tau) but not with total tau in the temporal and frontal cortex [63], supporting a role of UFM1 as tau aggregation modifier in AD. Here, MAPT is linked to Alzheimer disease.